KCM
RXDX

Kennedy Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Kennedy Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,348
Closed -$1M – 708
2023
Q1 		$1M Buy
+9,348
New +$1M 0.03% 486